FDA Rejects Mylan's Application For Generic Advair
The U.S. Food & Drug Administration has decided not to approve Mylan's abbreviated new drug application for a generic version of GlaxoSmithKline's blockbuster inhaled asthma medication Advair Diskus, Mylan said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article